MedPath

Idorsia Pharmaceuticals Deutschland GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

CIMA_AEMPS:2
EMA:1

Drug Approvals

Quviviq

Authorization Status
Authorised
Approval Date
Apr 29, 2022
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.